Achieving Treatment Goals in Low-Risk, Asymptomatic Patients

Ferdinand, Keith C. 2010

Traditional risk factor assessments for coronary heart disease (CHD) often fail to take into account individual factors such as race and lipid profiles that may substantially elevate a patient’s risk for CHD or a cardiovascular event. Although numerous treatment guidelines have been issued ...

Alzheimer DiseaseUpdate on Basic Mechanisms

Bi, Xiaoning 2010

Alzheimer disease is the most common form of dementia in the aged population. Pathologically, Alzheimer disease is characterized by progressive synaptic and neuronal loss and the presence of diagnostic amyloid plaques, consisting of fibril b-amyloid peptide aggregates and neurofibrillary ...

Cost-Effectiveness of Rosuvastatin for Primary Prevention of Cardiovascular Events According to Framingham Risk Score in Patients With Elevated C-Reactive Protein

MacDonald, G. P. 2010

In Table 3 under “FRS >10%” for “Cost of statin per tablet,” the corresponding amount in the column “Biased Toward Statin” was incorrectly printed as $1000. This amount should have been -$1000. In addition, the blue graph line in Figure 4was incorrectly labeled “Framingham Risk Score <10%.” ...

Improving Outcomes in Patients With Type 2 Diabetes MellitusPractical Solutions for Clinical Challenges

Gavin, James R.; Stolar, Mark W.; Freeman, Jeffrey S.; Spellman, Craig W. 2010

The incidence and prevalence of type 2 diabetes mellitus (T2DM) in the United States continue to rise, and the disease has become an enormous health concern. While effective glycemic management reduces the risk of diabetes-related complications in patients with T2DM, many patients are unable to ...